Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countries
GI cancer incidence and deaths are expected to nearly double by 2050, with increases across sexes, cancer types, and regions, especially in lower HDI countries.
Authors
- Kwanjit Duangsonk (ORCID: https://orcid.org/0000-0002-3325-1688)
- Lewis R. Roberts (ORCID: https://orcid.org/0000-0001-7885-8574)
- Disatorn Dejvajara (ORCID: https://orcid.org/0000-0002-0549-202X)
- Mark Dhinesh Muthiah (ORCID: https://orcid.org/0000-0002-9724-4743)
- Pojsakorn Danpanichkul (ORCID: https://orcid.org/0000-0002-9121-165X)
- Michael Wallace
- Ghassan K. Abou‐Alfa (ORCID: https://orcid.org/0000-0002-1522-8054)
- Pongpun Saokhieo (ORCID: https://orcid.org/0009-0003-3695-6936)
- Primrose Tothanarungroj
- Diego Olavarria Bernal (ORCID: https://orcid.org/0009-0005-6128-9017)
- Yanfang Pang
- Donghee Kim
- Rashid N. Lui
- Karn Wijarnpreecha
- Amit G. Singal
- Kanokphong Suparan
- Ju Dong Yang
Institutions
- Texas Tech University (US)
- Cedars-Sinai Medical Center (US)
- Mayo Clinic (US)
- Memorial Sloan Kettering Cancer Center (US)
- University of Arizona (US)
- National University of Singapore (SG)
- Chinese University of Hong Kong (HK)
- Trinity College Dublin (IE)
- Cornell University (US)
- Jacksonville College (US)
- WinnMed (US)
- Banner - University Medical Center Phoenix (US)
- Affiliated Hospital of Youjiang Medical University for Nationalities (CN)
- Mayo Clinic in Florida (US)
- Chiang Mai University (TH)
- The University of Texas Southwestern Medical Center (US)
- Texas Tech University Health Sciences Center (US)
- Stanford University (US)
Publication Details
- Journal
- Cancer
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1002/cncr.70245
- Citations
- 3
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 6.02
Funders
- National Institutes of Health